NeutriSci International Inc. (NRXCF) Comparison with companies in other sectors?

NeutriSci International Inc. has a share price of 655.28B. You can analyze NeutriSci International Inc. (NRXCF) competitors across different market sectors through stock heatmaps.

What are NRXCF's NET and operating margins?

NeutriSci International Inc. (NRXCF) operating margin is around -1.51, and net profit margin is approximately -1.68 as of the latest reports.

In what way does NRXCF's earnings per share (EPS) trend reflect its financial momentum?

NeutriSci International Inc. (NRXCF) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for NeutriSci International Inc. is -0.22, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for NeutriSci International Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for NeutriSci International Inc. like P/E which is -0.38, P/B which is -0.48, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

NeutriSci International Inc.

NRXCF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$0.001

$0.00(0.00%)

Fundamental Analysis of NeutriSci International Inc. (NRXCF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.01

P/E Ratio

-0.22

ROE

2.32%

Net Margin

-1.68%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$851.86M

Shares OutstandingTotal number of shares issued

$655.28B

Book Value/ShareNet worth per share

$-0.00

Revenue/ShareAnnual revenue per share

$0.003

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.006

Net MarginNet income as percentage of revenue

-168.37%

Operating MarginOperating income as percentage of revenue

-150.81%

ROEReturn on shareholders' equity

231.94%

ROAReturn on total assets

-232.54%

ROCEReturn on capital employed

123.94%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.00

Cash/ShareCash and equivalents per share

$0.001

FCF YieldFree cash flow as percentage of market cap

-0.01%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NRXCFFinancial Ratios Analysis details for NRXCF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NRXCFSector Benchmarking details for NRXCF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for NeutriSci International Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of NeutriSci International Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account NeutriSci International Inc.'s unique business strengths and challenges.

Key Financial Metrics for NeutriSci International Inc.

For NeutriSci International Inc., essential financial indicators include EPS -0.01, PE -0.22, and ROE 2.32. These key ratios reveal insights into NeutriSci International Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare NeutriSci International Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of NeutriSci International Inc.

Metrics like Net Margin -168.37% and ROA -232.54% shed light on how well NeutriSci International Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether NeutriSci International Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of NeutriSci International Inc.

Using ratios such as P/B Ratio -0.48 and PEG Ratio -0.00, investors can assess whether NeutriSci International Inc. is appropriately valued based on its financials and growth potential. These figures, combined with NeutriSci International Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for NeutriSci International Inc.

Financial health indicators, such as Debt/Equity Ratio -0.29 and Cash Flow $-0.00, provide a snapshot of NeutriSci International Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like NeutriSci International Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for NeutriSci International Inc.

Investing in NeutriSci International Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at NeutriSci International Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;